This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked CALCR Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-CALCR WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~55.3 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Hypothalamus (IHC candidate; verify WB) +2 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Glycosylated + Cleaved | |
| Caveat | Glycosylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 6 isoform(s) |
The A03322-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | lysate from MCF-7, A431 cell line, (catalog A03322-1) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A03322-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | 1:5000 (catalog A03322-1) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
CALCR has a predicted 55.3 kDa precursor; glycosylation, signal-peptide cleavage and isoforms may affect migration, but no empirical band size is supplied.
| Band near 55.3 kDa | consistent with the predicted full-length precursor; confirm identity with controls |
| Band above 55.3 kDa | may reflect N-linked glycosylation at Asn28, Asn73, Asn125 or Asn130 |
| Band below 55.3 kDa | may reflect removal of the 1–24 signal peptide |
| Multiple bands | could reflect isoforms 1–6, though distinct migration is unestablished |
| Weak or absent lysate band | the membrane receptor may be poorly recovered during extraction |
| Predicted full-length mass | sets a 55.3 kDa precursor reference, not a measured band |
| N-linked glycosylation at Asn28 | may increase apparent size if occupied |
| N-linked glycosylation at Asn73 | may increase apparent size if occupied |
| N-linked glycosylation at Asn125 | may increase apparent size if occupied |
| N-linked glycosylation at Asn130 | may increase apparent size if occupied |
| Signal peptide at residues 1–24 | cleavage yields a smaller mature chain than the precursor |
| Isoforms 1, 2, 3, 4, 5 and 6 | may differ in size; their masses and separation are unspecified |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | CALCR is a multi-pass membrane protein that may be poorly extracted | Check membrane protein recovery and use a membrane-enriched preparation |
| Band higher than expected | N-linked glycans at the four listed asparagines may affect migration | Compare matched samples before and after N-glycan removal |
| Band lower than expected | Signal-peptide cleavage can reduce size relative to the full-length precursor | Check the antibody epitope and verify band identity by peptide competition |
| Broad smear instead of sharp band | Variable N-linked glycosylation is possible but unconfirmed | Compare matched samples before and after N-glycan removal |
| Multiple bands | CALCR has six named isoforms, but their migration is unspecified | Verify candidate bands by peptide competition and compare isoform expression |
| Weak or no signal | Recovery of the multi-pass membrane receptor may be inefficient | Assess extraction and membrane enrichment before interpreting absence |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Hypothalamus | neuronal cells | High | Protein (IHC) | HPA → |
| Kidney | distal tubules | Medium | Protein (IHC) | HPA → |
| Placenta | syncytiotrophoblasts - cell body | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for CALCR, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A03322-1 is a human-reactive anti-CALCR antibody with a Western blot image using MCF-7 and A431 lysates, with and without peptide. The supplied evidence is limited to this example.
Which to pick: A03322-1 is the only listed option. Its WB example uses MCF-7 and A431 lysates at 35 µg per lane and a 1:1000 primary antibody dilution; assess its suitability for your sample.